Chronic administration of the triazolobenzodiazepine alprazolam produces opposite effects on corticotropin-releasing factor and urocortin neuronal systems

Journal of Neuroscience

Volumn 20, Issue 3, 2000, Pages 1240-1248

  Skelton, Kelly H ^a   Nemeroff, Charles B ^a   Knight, David L ^a   Owens, Michael J ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Amygdala; Anxiety; Benzodiazepines; Corticotropin releasing factor; Locus coeruleus; Stress; Urocortin

Indexed keywords

ALPRAZOLAM; CORTICOTROPIN RELEASING FACTOR; MESSENGER RNA; UROCORTIN;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN; CONTROLLED STUDY; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; LOCUS CERULEUS; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RECEPTOR BINDING; SEPTUM PELLUCIDUM; STRESS; ZONA INCERTA;

EID: 0034143267     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.20-03-01240.2000     Document Type: Article

References (82)

1. Adinoff B, Anton R, Linnoila M, Guidotti A, Nemeroff CB, Bissette G (1996) Cerebrospinal fluid concentrations of corticotropin-releasing hormone (CRH) and diazepam-binding inhibitor (DBI) during alcohol withdrawal and abstinence. Neuropsychopharmacology 15:288-295.
2. Albeck D, McKittrick C, Blanchard D, Blanchard R, Nikulina J, McEwen B, Sakai R (1997) Chronic social stress alters levels of corticotropin-releasing factor and arginine vasopressin mRNA in rat brain. J Neurosci 17:4895-4903.
3. Altemus M, Smith M, Diep V, Aulakh C, Murphy D (1994-1995) Increased mRNA for corticotrophin releasing hormone in the amygdala of fawn-hooded rats: a potential animal model of anxiety. Anxiety 1:251-257.
4. Baker DG, West SA, Nicholson WE, Ekhator NN, Kasckow JW, Hill KK, Bruce AB, Orth DN, Geracioti Jr TD (1999) Serial CSF corticotropin-releasing hormone levels and adrenocortical activity in combat veterans with posttraumatic stress disorder. Am J Psychiatry 156:585-588.
5. Bremner J, Licinio J, Darnell A, Krystal JH, Owens MJ, Southwick SM, Nemeroff CB, Charney DS (1997) Elevated CSF corticotropin-releasing factor concentrations in posttraumatic stress disorder. Am J Psychiatry 154:624-629.
6. Britton K, Morgan J, Rivier J, Vale W, Koob GF (1985) Chlordiazepoxide attenuates CRF-induced response suppression in the conflict test. Psychopharmacology (Berl) 86:170-174.
7. Butler PD, Weiss JM, Stout JC, Nemeroff CB (1990) Corticotropin-releasing factor produces fear-enhancing and behavioral activating effects following infusion into the locus coeruleus. J Neurosci 10:176-183.
8. Caldji C, Tannenbaum B, Sharma S, Francis D, Plotsky P, Meancy M (1998) Maternal care during infancy regulates the development of neural systems mediating the expression of fearfulness in the rat. Proc Natl Acad Sci USA 95:5335-5340.
9. Chalmers DT, Lovenberg TW, Grigoriadis DE, Behan DP, De Souza EB (1996) Corticotrophin-relcasing factor receptors: from molecular biology to drug design. Trends Pharmacol Sci 17:166-172.
10. Chappell PB, Smith MA, Kilts CD, Bissette G, Ritchie J, Erson C, Nemeroff CB (1986) Alterations in corticotropin-releasing factor-like immunoreactivity in discrete rat brain regions after acute and chronic stress. J Neurosci 6:2908-2914.
11. Charney DS, Brcmner JD, Redmond DE (1995) Noradrenergic neural substrates for anxiety and fear: clinical associations based on prcclinical research. In: Psychopharmacology: the fourth generation of progress (Bloom FE, Kupfer DJ, eds), pp 387-395. New York: Raven.
12. Conti LH, Foote SL (1996) Reciprocal cross-desensitization of locus coeruleus electrophysiological responsivity to corticotropin-releasing factor and stress. Brain Res 722:19-29.
13. Cowley DS, Roy-Byrne PP, Radant A, Ritchie JC, Greenblatt DJ, Nemeroff CB, Hommer DW (1995) Benzodiazcpine sensitivity in panic-disorder: effects of chronic alprazolam treatment. Neuropsychopharmacology 12:147-157.
14. Denenberg VH (1964) Critical periods, stimuli input, and emotional reactivity: a theory of infantile stimulation. Psychol Rev 71:335-351.
15. De Souza EB, Insel TR, Perrin MH, Rivier J, Vale WW, Kuhar MJ (1985) Corticotropin-releasing factor receptors are widely distributed within the rat central nervous system: an autoradiographic study. J Neurosci 5:3189-3203.
16. Donaldson CJ, Sutton SW, Perrin MH, Corrigan AZ, Lewis KA, Rivier JE, Vaughan JM, Vale WW (1996) Cloning and characterization of human urocortin. Endocrinology [Erratum (1996) 137:3896] 137: 2167-2170.
17. Dunn AJ, Berridge CW (1990) Physiological and behavioral responses to corticotropin-releasing factor administration: is CRF a mediator of anxiety or stress responses? Brain Res Rev 15:71-100.
18. Dunn AJ, File SE (1987) Corticotropin-releasing factor has an anxiogenic action in the social interaction test. Horm Behav 21:193-202.
19. Eghbal-Ahmadi M, Hatalski CG, Avishai-Eliner S, Baram TZ (1997) Corticotropin releasing factor receptor type II (CRF2) messenger ribonucleic acid levels in the hypothalamic ventromedial nucleus of the infant rat are reduced by maternal deprivation. Endocrinology 138:5048-5051.
20. 2) in hypothalamus and amygdala of the immature rat by sensory input and food intake. J Neurosci 19:3982-3991.
21. Francis D, Diorio J, LaPlantc P, Weaver S, Seckl JR, Meaney MJ (1996) The role of early environmental events in regulating neuroendocrine development. Moms, pups, stress, and glucocorticoid receptors. Ann NY Acad Sci 794:136-152.
22. Fuchs E, Flugge G (1995) Modulation of binding sites for corticotropin-releasing hormone by chronic psychosocial stress. Psychoneuroendocrinology 20:33-51.
23. Gray TS, Bingaman EW (1996) The amygdala: corticotropin-releasing factor, steroids, and stress. Crit Rev Neurobiol 10:155-168.
24. Griebel G, Perrault G, Sanger D (1998) Characterization of the behavioral profile of the non-peptide CRF receptor antagonist CP-154,526 in anxiety models in rodents. Comparison with diazepam and buspirone. Psychopharmacology (Berl) 138:55-66.
25. Hara Y, Ueta Y, Isse T, Kabashima N, Shibuya I, Hattori Y, Yamashita H (1997a) Increase of urocortin-like immunoreactivity in the rat hypothalamo-neurohypophysial system after salt loading and hypophysectomy. Neurosci Lett 227:127-130.
26. Hara Y, Ueta Y, Isse T, Kabashima N, Shibuya I, Haltori Y, Yamashita H (1997b) Increase of urocortin-like immunoreactivity in the rat supraoptic nucleus after dehydration but not food deprivation. Neurosci Lett 229:65-68.
27. Hatalski CG, Guiguis C, Baram T (1998) Corticotropin releasing factor mRNA expression in the hypothalamic paraventricular nucleus and the central nucleus of the amygdala is modulated by repeated acute stress in the immature rat. J Neuroendocrinol 10:663-669.
28. Hawley RJ, Nemeroff CB, Bisscttc G, Guidotti A, Rawlings R, Linnoila M (1994) Neurochemical correlates of sympathetic activation during severe alcohol withdrawal. Alcohol Clin Exp Res 18:1312-1316.
29. Heinrichs SC, Pich EM, Miczek K, Britton KT, Koob GF (1992) Corticotropin-releasing factor antagonist reduces emotionality in socially defeated rats via direct neurotropic action. Brain Res 581:190-197.
30. Heinrichs SC, Min H, Tamraz S, Carmouche M, Boehme SA, Vale WW (1997a) Anti-sexual and anxiogenic behavioral consequences of corticotropin-releasing factor overexpression are centrally mediated. Psychoneuroendocrinology 22:215-224.
31. 2, receptors mediate anxiogenic-like behavior. Regul Pcpt 71:15-21.
32. Hsu DT, Chen FL, Takahashi LK, Kalin NH (1998) Rapid stress-induced elevations in corticotropin-releasing hormone mRNA in rat central amygdala nucleus and hypothalamic paraventricular nucleus: an in situ hybridization analysis. Brain Res 788:305-310.
33. Imaki T, Nahon JL, Rivier C, Sawchenko PE, Vale W (1991) Differential regulation of corticotropin-releasing factor mRNA in rat brain regions by glucocorticoids and stress. J Neurosci 11:585-599.
34. Imaki T, Wang XQ, Shihasaki T, Harada S, Chikada N, Takahashi C, Naruse M, Demura H (1995) Chlordiazepoxide attenuates stress-induced activation of neurons, corticotropin-releasing factor (CRF) gene transcription and CRF biosynthesis in the paraventricular nucleus (PVN). Mol Brain Res 32:261-270.
35. Imaki T, Naruse M, Harada S, Chikada N, Imaki J, Onodera H, Demura H, Vale W (1996) Corticotropin-releasing factor up-regulates its own receptor mRNA in the paraventricular nucleus of the hypothalamus. Brain Res Mol Brain Res 38:166-170.
36. Kalin NH, Takahashi LK, Chen F-L (1994) Restraint stress increases corticotropin-releasing hormone mRNA content in the amygdala and paraventricular nucleus. Brain Res 656:182-186.
37. Kalogeras KT, Calogero AE, Kuribayiashi T, Kahn J, Gallucci WT, Kling MA, Chrousos GP, Gold PW (1990) In vitro and in vivo effects of the triazolobenzodiazepine alprazolam on hypothalamic-pituitary-adrenal function: pharmacological and clinical implications. J Clin Endocrinol Metab 70:1462-1471.
38. Kiss A, Palkovits M, Aguilera G (1996) Neural regulation of corticotropin releasing hormone (CRH) and CRH receptor mRNA in the hypothalamic paraventricular nucleus in the rat. J Neuroendocrinol 8:103-112.
39. Koegler-Muly SM, Owens MJ, Ervin GN, Kilts CD, Nemeroff CB (1993) Potential corticotropin-releasing factor pathways in the rat brain as determined by bilateral electrolytic lesions of the central amygdaloid nucleus and paraventricular nucleus of the hypothalamus. J Neuroendocrinol 5:95-98.
40. Kozicz T, Yanaihara H, Arimura A (1998) Distribution of urocortin-like immunoreactivity in the central nervous system of the rat. J Comp Neurol 391:1-10.
41. Krahn DD, Gosnell BA, Levine AS, Morley JE (1988) Behavioral effects of corticotropin-releasing factor: localization and characterization of central effects. Brain Res 443:63-69.
42. Krulik R, Cerny M (1971) Effects of chlordiazepoxidc on stress in rats. Life Sci 10:145-151.
43. Ladd CO, Owens MJ, Nemeroff CB (1996) Persistent changes in corticotropin-releasing factor neuronal systems induced by maternal deprivation. Endocrinology 137:1212-1218.
44. Ladd CO, Huot RL, Thrivikraman KV, Nemeroff CB, Meancy MJ, Plotsky PM (2000) Long-term behavioral and neuroendocrine adaptations to adverse early experience. In: Progress in brain research: the biological basis for mind body interactions (Mayer E, Saper C, eds), pp 79-101. Amsterdam: Elsevier.
45. Lee Y, Davis M (1997) Role of the hippocampus, the bed nucleus of the stria terminalis, and the amygdala in the excitatory effect of corticotropin-releasing hormone on the acoustic startle reflex. J Neurosci 17:6434-6446.
46. Levine S (1957) Infantile experience and resistance to physiological stress. Science 126:405-406.
47. 1 receptor antisense oligodeoxynucleotide into the central nucleus of the amygdala reduced anxiety-related behavior in socially defeated rats. Regul Pept 59:229-239.
48. Liebsch G, Landgraf R, Engelmann P, Lorscher P, Holsboer F (1999) Chronic infusion of CRH1 or CRH2 receptor antisense oligonucleotides into the rat brain differentially affects emotional and stress coping behavior. J Psychiatr Res 33:153-163.
49. Lundkvist J, Chai Z, Teheranian R, Hasanvan H, Bartfai T, Jenck F, Widmer U, Moreau J-L (1996) A non peptidic corticotropin releasing factor receptor antagonist attenuates fever and inhibits anxiolytic-like activity. Eur J Pharmacol 309:195-200.
50. Mansi JA, Rivest S, Drolet G (1996) Regulation of corticotropin-releasing factor type 1 (CRF1) receptor messenger ribonucleic acid in the paraventricular nucleus of rat hypothalamus by exogenous CRF. Endocrinology 137:4619-4629.
51. 2 receptors. Am J Physiol 274:G695-G700.
52. Owens MJ, Nemeroff CB (1991) Physiology and pharmacology of corticotropin-relcasing factor. Pharmacol Rev 43:425-473.
53. Owens MJ, Bissette G, Nemeroff CB (1989) Acute effects of alprazolam and adinazolam on the concentrations of corticotropin-releasing factor in the rat brain. Synapse 4:196-202.
54. Owens MJ, Vargas MA, Knight DL, Nemeroff CB (1991) The effects of alprazolam on corticotropin-releasing factor neurons in the rat brain: acute time course, chronic treatment and abrupt withdrawal. J Pharmacol Exp Ther 258:349-356.
55. Owens MJ, Mulchahey JJ, Stout SC, Plotsky PM (1997) Molecular and neurobiological mechanisms in the treatment of psychiatric disorders. In: Psychiatry (Tasman A, Kay J, Liebcrman JA, eds), pp 210-257. Philadelphia: Saunders.
56. Paxinos G, Watson C (1986) The rat brain in stereotaxic coordinates. San Diego: Harcourt Brace Jovanovich.
57. Pich EM, Lorang M, Yeganeh M, Rodriguez de Fonscca F, Raber J, Koob GF, Weiss F (1995) Increase of extracellular corticotropin-releasing factor-like immunoreactivity levels in the amygdala of awake rats during restraint stress and ethanol withdrawal as measured by microdialysis. J Neurosci 15:5439-5447.
58. Primus RJ, Yevich E, Baltazar C, Gallager DW (1997) Autoradiographic localization of CRF1 and CRF2 binding sites in adult rat brain, Neuropsychopharmacology 17:308-316.
59. Radulovic J, Ruhmann A, Liepold T, Spiess J (1999) Modulation of learning and anxiety by corticotropin-releasing factor (CRF) and stress: differential roles of CRF receptors 1 and 2. J Neurosci 19:5016-5025.
60. Rassnick S, Heinrichs SC, Britton KT, Koob GF (1993) Microinjection of a corticotropin-releasing factor antagonist into the central nucleus of the amygdala reverses anxiogenic-like effects of ethanol withdrawal. Brain Res 605:25-32.
61. Redmond DE (1987) Studies of the nucleus locus coeruleus in monkeys and hypotheses for neuropsychopharmacology. In: Psychopharmacology: the third generation of progress (HY Meltzer, ed), pp 967-976. New York: Raven.
62. Richter RM, Weiss F (1999) In vivo CRF release in rat amygdala is increased during cocaine withdrawal in self-administering rats. Synapse 32:254-261.
63. Rohrer T, Von Richthofen V, Schulz C, Beyer J, Lehnert H (1994) The stress-, but not corticotropin-releasing hormone-induced activation of the pituitary-adrenal axis in man is blocked by alprazolam. Horm Metab Res 26:200-206.
64. Sanchez MM, Young LJ, Plotsky PM, Insel TR (1999) Autoradiographic and in situ hybridization localization of corticotropin-releasing factor 1 and 2 receptors in nonhuman primate brain. J Comp Neurol 408:365-377.
65. Simmons DM, Arriza JL, Swanson LW (1989) A complete protocol for in situ hybridization of messenger RNAs in brain and other tissues with radiolabcled single-stranded RNA probes. J Histotechnol 12:169-181.
66. Skutella T, Criswell H, Moy S, Probst JC, Breese GR, Jirikowski GF, Holsboer F (1994) Corticotropin releasing hormone (CRH) antisense oligodeoxynucleotide induces anxiolytic effects in rat. NeuroReport 5:2181-2185.
67. Smagin G, Howell L, Ryan D, DeSouza E, Harris R (1998) The role of CRH2 receptors in corticotropin-releasing factor- and urocortin-induced anorexia. NeuroReport 9:1601-1606.
68. Smagin GN, Harris RB, Ryan DH (1996) Corticotropin-releasing factor receptor antagonist infused into the locus coeruleus attenuates immobilization stress-induced defensive withdrawal in rats. Neurosci Lett 220:167-170.
69. Smagin GN, Zhou J, Harris RB, Ryan DH (1997) CRF receptor antagonist attenuates immobilization stress-induced norepinephrinc release in the prefrontal cortex in rats. Brain Res Bull 42:431-434.
70. Spina M, Merlo-Pich E, Chan RKW, Basso AM, Rivier J, Vale W, Koob GF (1996) Appetite-suppressing effects of urocortin, a CRF-related ncuropeptide. Science 273:1561-1564.
71. Swanson LW, Sawchenko PE, Rivier J, Vale WW (1983) Organization of ovine corticotropin-releasing factor immunorcactive cells and fibers in the rat brain: an immunohistochemical study. Neuroendocrinology 36:165-186.
72. Swerdlow NR, Geyer MA, Vale WW, Koob GF (1986) Corticotropin releasing factor potentiates acoustic startle in rats: blockade by chlordiazepoxide. Psychopharmacology (Berl) 88:147-152.
73. Swiergiel AH, Takahashi LK, Rubin WW, Kalin NH (1992) Antagonism of corticotropin-releasing factor receptors in the locus coeruleus attenuates shock-induced freezing in rats. Brain Res 587:263-268.
74. Swiergiel AH, Takahashi LK, Kalin NH (1993) Attenuation of stress-induced behavior by antagonism of corticotropin-releasing factor receptors in the central amygdala in the rat. Brain Res 623:229-234.
75. Timpl P, Spanagel R, Sillaber I, Kresse A, Reul J, Stalla G, Blanquet V, Sleckler T, Holsboer F, Wurst W (1998) Impaired stress response and reduced anxiety in mice lacking a functional corticotropin-releasing hormone receptor. Nat Genet 19:162-166.
76. Valentino RJ, Foote SL, Page ME (1993) The locus coeruleus as a site for integrating corticotropin-releasing factor and noradrcnergic mediation of stress responses. Ann NY Acad Sci 697:173-188.
77. Van Bockstaele EJ, Colago EE, Valentino RJ (1996) Corticotropin-releasing factor-containing axon terminals synapse onto catecholamine dendrites and may presynaptically modulate other afferents in the rostral pole of the nucleus locus coeruleus in the rat brain. J Comp Neurol 364:523-534.
78. Van Bockstaele EJ, Colago EE, Valentino RJ (1998) Amygdaloid corticotropin-releasing factor targets locus coeruleus dendrites: substrate for the co-ordination of emotional and cognitive limbs of the stress response. J Neuroendocrinol 10:743-757.
79. Vaughan J, Donaldson C, Bittencourt J, Perrin MH, Lewis K, Sutton S, Chan R, Turnbull AV, Lovejoy D, Rivier C, Rivier J, Sawchenko PE, Vale W (1995) Urocortin, a mammalian neuropcptide related to fish urotensin I and to corticotropin-releasing factor. Nature 378:287-292.
80. Weiss JM, Stout JC, Aaron MF, Quan N, Owens MJ, Butler PD, Nemeroff CB (1994) Depression and anxiety: role of the locus coeruleus and corticotropin-releasing factor, Brain Res Bull 35:561-572.
81. Wong M-L, Al-Shekkhlce A, Bongiorno PB, Esposito A, Khatri P, Sternberg EM, Gold PW, Licinio J (1996) Localization of urocortin messenger RNA in rat brain and pituitary. Mol Psychiatry 1:307-312.
82. Zhao L, Donaldson C, Smith G, Vale W (1998) The structures of the mouse and human urocortin genes (Ucn and UCN). Genomics 50:28-38.